Overview

Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

Status:
Recruiting
Trial end date:
2020-11-01
Target enrollment:
0
Participant gender:
Female
Summary
In this study, the investigators will assess the efficacy of growth hormone co-stimulation to GnRH antagonist regimen in poor responders to COH for IVF.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Riyadh Fertility and Reproductive Health center
Treatments:
Hormones
Prolactin Release-Inhibiting Factors
Criteria
Inclusion Criteria:

- Serum anti-Müllerian hormone (AMH) less than 1.2 ng/ml

Exclusion Criteria:

-